APTOF - Aptose Biosciences Inc.
1.6117
-0.024 -1.508%
Share volume: 9,327
Last Updated: 03-27-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$1.64
-0.02
-0.01%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-08-2025 | 08-13-2025 | 11-13-2025 | |
| Assets | ||||
| Total Assets | 7.467 M | 5.591 M | 6.341 M | |
| Current Assets | 6.969 M | 3.271 M | 3.777 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 274.000 K | 116.000 K | 127.000 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 4.743 M | 553.000 K | 613.000 K | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 23.000 K | 19.000 K | 8.000 K | |
| Other Assets | 475.000 K | 2.301 M | 2.556 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 7.467 M | 5.591 M | 6.341 M | |
| Total liabilities | 14.860 M | 19.962 M | 25.791 M | |
| Total current liabilities | 6.318 M | 9.000 M | 7.079 M | |
| Accounts Payable | 2.390 M | 2.879 M | 1.456 M | |
| Other liabilities | 8.462 M | 10.962 M | 18.712 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 8.462 M | 10.962 M | 18.712 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -7.393 M | -14.371 M | -19.450 M | |
| Common stock | 543.433 M | 543.498 M | 543.542 M | |
| Retained earnings | -546.510 M | -553.553 M | -558.676 M |